Promacta 50 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F23W7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,459
Award facts
- Contract value 100% obligated
- $8,458.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $8,458.73 delivery order to AmerisourceBergen Drug Corp for 30-count units of Promacta 50 mg tablets, with an ultimate completion date of January 2, 2026. This is a firm fixed price, non-set-aside contract awarded on December 10, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical federal vendor for military and veteran healthcare systems. The company's extensive federal contract portfolio with the Defense Logistics Agency and Medical Supply Chain demonstrates capability across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This particular delivery order for Promacta—an immunosuppressant medication used to treat thrombocytopenia—exemplifies the company's role in providing essential pharmaceutical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitive procurement mechanisms.
Quick answers
Who was awarded contract SPE2DR26F23W7?
SPE2DR26F23W7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26F23W7 worth?
The government has obligated $8,459 on SPE2DR26F23W7.
Is contract SPE2DR26F23W7 an order under another contract?
Yes. SPE2DR26F23W7 is a delivery order under SPE2DR25D1047, an indefinite delivery contract.
Was contract SPE2DR26F23W7 competed?
The extent of competition for SPE2DR26F23W7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award